True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Cognitive neuroenhancement: false assumptions in the ethical debate
- Neuroenhancers, addiction and research ethics
- Sugar addiction: is it real? A narrative review
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
- Neuropsychiatry of the basal ganglia
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Neuroenhancing public health
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- The billion dollar business of being smart
- GL.01 Dopamine in health and disease